Table 2.
Clinical Features, Treatments, and Follow-up of Patients with Pancreatic Metastases from Colorectal Cancer Diagnosed by EUS-FNA.
| Reference | No. | Age (years) | Sex | Primary site | Metachronous pulmonary metasatsis | Interval (months) | Site | Size (mm) | EUS-FNA | Surgery | Follow-up (months) | Outcome | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytological diagnosis | Immunohistochemical findings | ||||||||||||
| 7 | 2 | 54 | M | Colon | - | 65 | NA | 70 | ADC | CK20+/CK7- | - | 16 | Death |
| 47 | M | Colon | - | NA | NA | 37 | ADC | CK20+/CK7- | - | NA | Unknown | ||
| 8 | 1 | 74 | M | Left colon | - | 24 | Body | 21 | ADC | - | DP | 6 | Alive |
| 4 | 2 | 67 | M | Rectal | + | 72 | Head/Body | 17/16 | ADC | CK20+/CK7- | MSPP | 16 | Alive |
| 58 | M | Rectal | + | 84 | Body | NA | ADC | CK20+/CK7- | DP | 6 | Alive | ||
| 9 | 4 | 62 | M3 | Colon (n = 4) | - | 65* | Head | 27* | ADC (n = 2) | - | - | NA | Death (n = 3) |
| F1 | (12-96) | (20-70) | ADC (n = 2) | CK20+/CK7-/CDX2+ | - | NA | Unknown (n = 1) | ||||||
| 10 | 1 | 67 | F | Right colon | - | 72 | Head | 40 | ADC | CK20+/CK7-/CDX2+ | - | NA | NA |
| 11 | 3 | 65 | F | Colon | - | 37 | NA | 25 | ADC | NA | PD | 12 | Death |
| 74 | F | Colon | - | 25 | NA | 12 | ADC | NA | EL | 13 | Death | ||
| 78 | F | Colon | - | 39 | NA | 12 | ADC | NA | - | 5 | Death | ||
| Present study | 1 | 77 | F | Rectal | + | 132 | Tail | 30 | ADC | CK20+/CK7-/CDX2+ | DP | 17 | Alive |
ADC: adenocarcinoma, CDX: caudal-related homeodomain protein, CK: cytokeratin, DP: distal pancreatectomy, EL: exploratory laparotomy, MSPP: middle-segmentpreserving pancreatectomy, NA: not applicable, PD: pancreaticoduodenectomy
* median (range)